Breast Biopsy: Types, Procedure, Report and What It Can and Cannot Tell You

Key takeaways

• Diagnosis needs tissue. Mammography, USG and MRI can suggest cancer; only a biopsy can confirm it.
• Type matters. Core needle biopsy is preferred when cancer is suspected, because it gives tissue architecture and receptor testing; fine needle aspiration gives only cells.
• A benign report is not always the final word. A biopsy samples a targeted area, and sampling can miss the lesion. Persistent or growing lumps need review.
• Most breast biopsies are outpatient procedures under local anaesthetic, with bruising and soreness being the usual after-effects. Results vary depending on individual clinical circumstances.
• Preparation and reporting times differ by hospital. Your unit's written instructions take precedence over any general guidance.

At a glance

Also known as

• Breast lump biopsy, breast tissue test
• FNAC breast (fine needle aspiration cytology)
• Trucut biopsy breast, a widely used Indian term for core needle biopsy
• USG-guided breast biopsy, sonography-guided breast biopsy
• Stereotactic (mammography-guided) breast biopsy
• Lumpectomy / excision biopsy (a surgical biopsy)

What a breast biopsy is

A breast biopsy is a targeted sampling procedure. Using a needle or a surgical incision, the doctor removes tissue or cells from a specific area of concern, usually one found on clinical examination or imaging. A pathologist then examines the sample.

The pathology report describes what the cells look like, whether they are benign, atypical or malignant, and if malignant, the tumour type and grade. On a cancer sample, further tests such as oestrogen receptor, progesterone receptor and HER2 are usually performed on the same tissue. These receptor tests need tissue cores or a surgical specimen; they generally cannot be done reliably on an FNAC smear alone.

For image-guided biopsies, a tiny metal marker clip may be placed at the site so the area can be relocated later if surgery is needed. This is standard practice in many units and is not a sign that cancer has been found.

Why a breast biopsy is done

• A lump, thickening or firm area felt in the breast or armpit that does not resolve
• A suspicious finding on mammography, breast ultrasound or breast MRI, for example a mass with irregular margins, suspicious microcalcifications, or distortion
• Blood-stained or spontaneous single-duct nipple discharge
• Persistent skin changes: dimpling, puckering, thickening, scaling or crusting of the nipple, or skin retraction
• A cyst that keeps refilling, or a cyst with solid components on ultrasound
• Suspected inflammatory breast changes or an abscess that is not responding to treatment as expected
• To sample an axillary lymph node that looks abnormal on imaging or examination
• To confirm disease in a suspected recurrence, or to obtain tissue for receptor testing before starting treatment

Who should get this test

A breast biopsy is a doctor-ordered procedure, not a screening test. A biopsy is generally appropriate for:

• Anyone with a discrete, persistent breast lump, including men, who can develop breast cancer
• Anyone with imaging classified as suspicious (commonly BI-RADS 4 or 5) on mammography, ultrasound or MRI
• People with a strong family history or known high-risk genetic finding who develop a new breast abnormality
• People with a previous breast cancer who develop a new lump, skin change or imaging abnormality
• People with abnormal axillary nodes where the primary problem is not yet known

A biopsy is usually not needed for clearly benign findings such as a simple cyst on ultrasound, or a typical fibroadenoma in a young woman that is stable on follow-up, though the decision rests with the treating doctor. Breast pain alone, without a lump or imaging abnormality, is rarely a reason for biopsy.

What a breast biopsy cannot detect or exclude

This is the part most often left out, and it matters.

• A biopsy samples one area, not the whole breast. A benign result applies to the tissue that was taken. Cancer elsewhere in the same breast or the other breast is not addressed.
• Sampling error happens. If the needle does not reach the lesion, the report may be benign while the lesion is not. This is why radiologists check "radiological-pathological concordance": if imaging looks highly suspicious but pathology is benign, repeat biopsy or surgical excision is often advised.
• "No malignant cells identified" is not the same as "cancer excluded." It describes what was seen in that sample. If your symptoms persist, the lump grows, or new changes appear despite a normal result, go back to your doctor.
• FNAC has real limits. Fine needle aspiration can be inconclusive or inadequate, cannot reliably distinguish DCIS from invasive cancer, and usually cannot provide grading or full receptor testing.
• A biopsy does not stage cancer. Tumour size, nodal involvement and spread to other organs need imaging and, often, surgery.
• A biopsy does not predict your treatment outcome. It provides information that feeds into treatment planning.
• Borderline results exist. Findings such as atypical ductal hyperplasia, lobular neoplasia, radial scar or papillary lesions are "uncertain" categories that often need surgical excision to settle, because a small proportion harbour cancer nearby.

Related but different examinations

These are frequently confused. They answer different questions and are not interchangeable.

Which biopsy comes first depends on the clinical problem

No single biopsy type is universally superior. The choice depends on what the lesion is and where it sits.

• Lump visible on ultrasound: ultrasound-guided core needle biopsy is usually the practical choice, real-time needle visualisation, no radiation, patient lies down.
• Suspicious microcalcifications seen only on mammography: stereotactic (mammography-guided) biopsy, often vacuum-assisted, because calcifications are usually not visible on ultrasound.
• Lesion seen only on MRI: MRI-guided biopsy, where available, or a targeted second-look ultrasound first.
• Suspected recurrent cyst or an abscess: aspiration may be both diagnostic and therapeutic.
• Enlarged axillary node: ultrasound-guided FNAC or core biopsy of the node.
• Lesion very close to the skin, nipple, chest wall or an implant, or not reachable by needle: surgical biopsy may be safer or necessary.

How to prepare

Preparation is an operational matter and varies between hospitals and by biopsy type. Follow the written instructions from the unit performing your biopsy, those instructions take precedence over anything here.

Points commonly covered:

• Medicines: tell your doctor about aspirin, clopidogrel, warfarin, acenocoumarol, newer oral anticoagulants, and any herbal or AYUSH supplement. Do not stop or change any prescribed medicine on your own: only the prescriber can advise whether and when to pause it.
• Allergies: report reactions to local anaesthetic, antiseptics, adhesive tape, latex or contrast agents.
• Fasting: usually not required for needle biopsies under local anaesthetic. Fasting is generally required if sedation or general anaesthesia is planned, and the duration is set by the anaesthetist.
• Clothing: a two-piece outfit and a well-fitting, supportive bra are helpful. Avoid deodorant, talc or lotion on the breast and underarm if a mammogram is part of the procedure.
• Positioning: stereotactic biopsy may require lying face down on a dedicated table, or sitting upright, for a period of time. Tell the team in advance if you have back, neck or shoulder problems, or difficulty lying still.
• Company: arrange someone to accompany you if sedation or anaesthesia is planned. Do not drive yourself home afterwards in that situation.
• Records: carry all previous mammogram, ultrasound and MRI films and reports. Comparison with earlier imaging genuinely changes decisions.

If you are pregnant or breastfeeding

Breast lumps during pregnancy and lactation still need proper evaluation, and pregnancy is not a reason to delay assessment. Ultrasound-guided biopsy is usually preferred because it avoids radiation. Tell the team if you are pregnant or might be, and if you are breastfeeding, milk fistula is an uncommon but recognised complication, and the team may advise on feeding or expressing around the procedure.

If you take anticoagulants or have a bleeding disorder

Bruising and haematoma risk is higher. The team may plan a smaller-gauge needle, longer compression, or coordinate timing with your physician or cardiologist. Never pause a blood thinner without instruction from the prescribing doctor, the risk of stopping can outweigh the bleeding risk of the biopsy.

If you have diabetes on glucose-lowering treatment

If fasting is required for sedation or anaesthesia, ask specifically how to handle insulin or oral agents that day. Fasting while continuing usual doses can cause hypoglycaemia. Carry a glucose source.

If you have a pacemaker, defibrillator or other implant

Ultrasound-guided and stereotactic biopsies are not a problem for cardiac devices. For MRI-guided biopsy, implants and devices require MRI safety assessment: many modern devices are conditionally MRI-safe, so this is an assessment, not an automatic exclusion. Bring the device identity card.

If you have breast implants

Biopsy is still possible, but technique is modified to avoid implant injury. Tell the team before the procedure.

Older adults and those with limited mobility

Positioning is the main practical hurdle, particularly for prone stereotactic tables. Upright or ultrasound-guided alternatives may be arranged.

What happens during a breast biopsy

The sequence differs by type, but the common pattern is:

• Consent and checks: the procedure, alternatives and risks are explained; imaging is reviewed to confirm the target.
• Positioning and cleaning: you lie down (or sit, or lie prone for some stereotactic systems). The skin is cleaned.
• Local anaesthetic: injected into the skin and deeper tissue. The initial sting is the most uncomfortable part for most people; after that you should feel pressure rather than sharp pain.
• Sampling: for core biopsy, a small nick is made and the needle is advanced under image guidance. You will hear a click or a low mechanical noise as each core is taken; several cores are usually needed. For vacuum-assisted biopsy, a suction device draws tissue into the needle.
• Marker clip: often placed at the site, then confirmed on a mammogram in some protocols.
• Closure and pressure: firm pressure for several minutes, then a dressing or adhesive strips. Sutures are usually needed only for surgical biopsy.
• Observation: a short period of monitoring before discharge; longer if sedation was used.

How long does the process take

The needle work itself is often only a few minutes. Realistic total time in the department is roughly 30 to 90 minutes for needle biopsies, including consent, positioning, imaging checks and post-procedure pressure. Surgical biopsy involves theatre scheduling, anaesthesia and recovery, so plan for most of a day. Actual timings depend on the unit's workflow and how straightforward the target is.

After the breast biopsy

• Soreness, bruising and mild swelling at the site are expected. Bruising typically fades over one to three weeks; a firm lumpy area from healing can take longer to settle.
• A cold pack over the dressing for short periods helps. Ask your team about simple pain relief, paracetamol is often suggested, and some units prefer you avoid aspirin-type painkillers initially.
• A supportive bra, worn day and night for the first day or two, reduces discomfort.
• Keep the dressing dry for the period your unit specifies. Avoid heavy lifting, gym work and swimming for the interval advised.
• For surgical biopsy, follow wound and suture instructions and attend the review appointment.

Understanding your report

A breast pathology report is descriptive. It should be read together with your imaging and examination by the doctor who requested it. Do not act on the report alone.

Categories you may see:

• Benign: fibroadenoma, fibrocystic change, fat necrosis, sclerosing adenosis, duct ectasia, granulomatous mastitis, or simple inflammation. No cancer in the sampled tissue.
• Benign but needing correlation: the diagnosis is benign, but if the imaging was highly suspicious the radiologist may still recommend repeat biopsy or excision.
• Uncertain malignant potential (often called B3): atypical ductal hyperplasia, lobular neoplasia, papillary lesion, radial scar, phyllodes tumour. These frequently require surgical excision for a complete answer.
• In-situ carcinoma: DCIS, abnormal cells confined within the ducts.
• Invasive carcinoma: with type (for example invasive ductal or lobular), grade, and usually ER, PR and HER2 status. Ki-67 may be reported.
• Inadequate or non-diagnostic: not enough usable material. Repeat sampling is needed. This is not a reassuring result and is not a benign result.

Receptor and HER2 results guide treatment choices. A negative receptor result does not mean untreatable, it means a different treatment pathway.

When results can be misleading

Falsely reassuring (benign when disease is present)

• Sampling miss: the needle passed beside the lesion rather than through it, the commonest reason.
• Small or scattered lesions: a few suspicious microcalcifications can be missed by a standard core needle; vacuum-assisted sampling reduces this.
• Inadequate cytology read as "no malignant cells": inadequate is not negative.
• Heterogeneous tumours: a core may show only the low-grade or in-situ component, with invasive disease found later at surgery.
• Deep, mobile or posterior lesions and lesions near an implant are technically harder to hit accurately.

Falsely alarming (suspicious when the process is benign)

• Recent trauma, surgery or radiotherapy can produce atypical-looking reactive cells and fat necrosis that mimic malignancy on imaging and occasionally on cytology.
• Pregnancy and lactation cause marked proliferative change; cytology can be over-called if the pathologist is not told about the pregnancy or feeding. Always declare it.
• Infection and granulomatous mastitis can produce clinically and radiologically worrying features.
• Prior needling can displace cells along the needle track, which pathologists must interpret with care.

If a report does not fit the clinical picture, ask about a second pathology opinion or repeat sampling. That is a normal, appropriate request.

Risks and safety

Breast biopsy is a commonly performed procedure with a low complication rate, but the risk profile differs by type. No procedure is free of risk, and results and recovery vary depending on individual clinical circumstances.

Fine needle aspiration

Least invasive. Minor pain, small bruise. Main drawback is diagnostic, inadequate or inconclusive samples are more frequent than with core biopsy.

Ultrasound-guided core needle biopsy

Local pain, bruising, small haematoma. Infection is uncommon. Rare complications include significant haematoma and, for lesions near the chest wall, pneumothorax, very infrequent but described. No ionising radiation.

Stereotactic biopsy

Involves a small dose of ionising radiation. Prone positioning can cause vasovagal faintness, neck or back discomfort. Bleeding risk similar to other core biopsies.

Vacuum-assisted biopsy

Removes more tissue, so bruising and haematoma are more likely than with standard core biopsy. Occasionally a small contour change at the site.

Surgical biopsy

Carries anaesthetic risk, a visible scar, seroma, wound infection, altered breast contour and occasionally persistent numbness or nerve discomfort. Reserved for specific indications.

MRI-guided biopsy

Adds contrast-related considerations and device safety assessment. Availability is limited.

Concerns that are often raised

There is no good evidence that a needle biopsy causes breast cancer to spread. Displacement of a few cells along the needle track has been described histologically, but it has not been shown to worsen outcomes, and delaying diagnosis carries a clear and definite harm.

Special situations

Pregnancy and lactation

Assessment should not be postponed. Ultrasound-guided core biopsy under local anaesthetic is generally the preferred route. Inform both the radiologist and the pathologist that you are pregnant or breastfeeding, as this changes how the tissue is interpreted.

Men

Male breast lumps are usually gynaecomastia, but male breast cancer occurs and often presents late. A firm, fixed, off-centre lump, skin change or nipple retraction in a man warrants imaging and, frequently, biopsy.

Adolescents and young women

Most lumps in this group are fibroadenomas. Ultrasound is the imaging of choice; biopsy is used selectively, guided by size, growth and clinical concern rather than done routinely.

Older adults

Needle biopsy under local anaesthetic is usually well tolerated and generally preferred over surgical biopsy. Anticoagulation, frailty and positioning need planning.

Chronic kidney disease and heart failure

Needle biopsies themselves are not affected. The considerations arise with contrast-enhanced MRI (kidney function assessment) and with lying flat or prone for long periods in heart failure. Tell the team about both conditions beforehand.

People with breast implants or prior breast surgery

Scar tissue and fat necrosis can mimic malignancy on imaging. Bring all prior operative and pathology records.

Breast biopsy in the Indian context

• Presentation is often late. Breast cancer is the commonest cancer among women in India, and a substantial proportion of patients present with locally advanced disease. Reluctance to investigate a lump, and repeated courses of empirical treatment for "breast pain", are recurring reasons for delay. A persistent lump deserves a definite answer.
• Dense breasts are common, particularly in younger women, which limits mammography and makes ultrasound and biopsy more important in the diagnostic pathway.
• Tuberculosis matters here. Breast tuberculosis and tubercular axillary lymphadenitis occur in India and can closely mimic cancer clinically and on imaging. Biopsy with appropriate additional testing distinguishes them. If you have been on anti-tubercular therapy, tell the team.
• Granulomatous mastitis is seen reasonably often and can present as a hard, worrying mass; diagnosis is histological.
• Terminology: "trucut biopsy" and "FNAC" are the everyday terms in Indian practice; "USG breast" means breast ultrasound. Ask which one is being planned, because they differ in what they can tell you.
• PC-PNDT Act 1994: this law governs the use of ultrasound for prenatal sex determination. Diagnostic breast ultrasound is unrelated to it, but registered ultrasound facilities in India operate under its record-keeping framework, and you may be asked to complete forms and show identity documents.
• Privacy: your pathology and imaging data are sensitive personal data under the Digital Personal Data Protection Act 2023. You are entitled to ask how your reports and images are stored and shared.
• Second opinions: for an uncertain or borderline breast pathology report, requesting review by a breast pathologist is reasonable and common practice. Request the slides or blocks along with the report.

Cost and insurance in India

Costs vary widely across cities, between government and private facilities, and by biopsy type. Government and trust hospitals often provide the procedure at nominal or subsidised rates. Any figure quoted online is indicative only; ask the performing facility for a written estimate before the procedure.

What drives the cost:

• Biopsy type: FNAC is the least expensive; core needle biopsy costs more; vacuum-assisted and MRI-guided biopsy are substantially more expensive. Surgical biopsy adds theatre, anaesthesia and stay charges.
• Imaging guidance used: ultrasound is cheaper than stereotactic mammography guidance, which is cheaper than MRI guidance.
• Consumables: biopsy needle or probe, marker clip, dressings.
• Pathology add-ons: immunohistochemistry for ER, PR, HER2, Ki-67, special stains, or molecular tests are billed separately and can exceed the biopsy cost itself.
• Anaesthesia and sedation, where used.
• Repeat procedures if the first sample is inadequate.
• City tier and hospital category.

Insurance: a diagnostic biopsy performed without hospital admission is often treated as an outpatient investigation and may not be covered unless your policy includes OPD diagnostics. Once a biopsy is part of an admitted procedure or cancer treatment pathway, coverage is more likely. Day-care and pre-hospitalisation clauses differ between policies. Government schemes including Ayushman Bharat PM-JAY cover cancer diagnosis and treatment packages for eligible beneficiaries at empanelled hospitals. Confirm approval and pre-authorisation with your insurer or the hospital's TPA desk before the procedure.

Myths and facts

Frequently asked questions

Is a breast biopsy painful?

Local anaesthetic is used, so most people feel the initial injection sting and then pressure rather than sharp pain. Soreness for a day or two afterwards is common. Lesions close to the nipple or chest wall, and dense breast tissue, can be more uncomfortable. Tell the team immediately if you feel sharp pain during sampling.

How long does a breast biopsy take?

The sampling itself often takes only a few minutes. Expect roughly 30 to 90 minutes in the department for a needle biopsy, covering consent, positioning, imaging checks and post-procedure pressure. Surgical biopsy requires theatre time and recovery, so plan for most of the day. Timings depend on the unit and the lesion.

When will I get my breast biopsy report?

Routine histopathology commonly takes a few working days. Reports needing immunohistochemistry for ER, PR and HER2, special stains or a second opinion take longer. Exact turnaround depends on the laboratory, so ask your unit for its expected date and a contact number to follow up if the report is delayed.

Can I go home the same day?

Needle biopsies under local anaesthetic are day procedures, and you can usually leave after a short observation period. If sedation or general anaesthesia was used, you will be monitored longer, must not drive, and should have someone accompany you. Surgical biopsy may require a short stay depending on the unit.

What should I avoid after a breast biopsy?

Avoid heavy lifting, strenuous exercise, swimming and gym work for the interval your unit advises, usually at least 24 hours for needle biopsies and longer after surgery. Keep the dressing dry as instructed. Ask the team before taking aspirin-type painkillers, and wear a supportive bra.

What if my biopsy report says the sample was inadequate?

An inadequate or non-diagnostic sample is not a benign result. It means there was not enough usable material to reach a conclusion, and repeat sampling, often with a larger needle or different guidance method, is usually recommended. Do not interpret it as reassurance and do not skip the follow-up appointment.

My biopsy is benign but the lump is still growing. What now?

Go back to the doctor who arranged the biopsy. A benign result describes only the tissue that was sampled, and sampling can miss a lesion. Growth, new skin or nipple changes, or imaging that remains suspicious are all reasons for repeat biopsy or surgical excision.

Do I need a biopsy for every breast lump?

No. Clearly benign findings such as a simple cyst on ultrasound, or